Lichen Sclerosus (Investigational Adjunct)

Patienten-Zusammenfassung

Ist dies FDA-zugelassen fuer diese Anwendung?

Not FDA-cleared for lichen sclerosus. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use for lichen sclerosus is investigational.

Welche Evidenz existiert?

Tier C (investigational). Only case reports; there are no randomized controlled trials. Evidence-based therapy for lichen sclerosus is ultra-potent topical corticosteroid (clobetasol propionate 0.05% once daily for 3 months, then maintenance) per AAD/BSGE guidelines. Topical calcineurin inhibitors as steroid-sparing. Vulvar disease requires gynecologic monitoring for squamous cell carcinoma risk (3-5 percent lifetime).

Hauptrisiken

• Bleeding from bite sites for 6 to 24 hours after detachment
• Worsening of fragile lichen sclerosus skin with trauma
• Local skin infection or, rarely, Aeromonas infection
• Allergic reaction to leech saliva (uncommon)
• Triggering of new lichen sclerosus lesions at bite sites (Koebner phenomenon)
• Scarring or distortion in fragile genital tissue
• Delay of clobetasol therapy and gynecologic SCC monitoring
• Risk of missed early squamous cell carcinoma in untreated disease

Wer dies nicht in Betracht ziehen sollte

• Patients with vulvar lichen sclerosus (gynecologic specialty care required)
• Patients with penile lichen sclerosus (urology referral)
• Patients with suspected squamous cell carcinoma (biopsy mandatory)
• Patients with active erosions, ulceration, or bleeding lesions
• Patients on anticoagulants, with hemophilia, or with severe anemia
• Patients who have not used clobetasol 0.05% consistently for 3 months

Was Sie Ihren Kliniker fragen sollten

• Has the diagnosis been confirmed by biopsy?
• Have I been screened for squamous cell carcinoma risk?
• Have I used clobetasol propionate 0.05% as directed for 3 months?
• Am I being monitored by a gynecologist or urologist for genital disease?
• What evidence specifically supports leech therapy for lichen sclerosus?
• Are leeches from an FDA-registered supplier and used only once?
• What is the cost and is it covered by insurance? (typically not covered)

Wann dringende medizinische Versorgung suchen

• New ulceration, persistent erosion, or new firm lump at any lichen sclerosus site (rule out SCC)
• Spreading redness, warmth, pus, or red streaks (cellulitis)
• Fever above 38.0 C / 100.4 F or chills
• Severe genital pain, bleeding, or urinary obstruction
• Bleeding from a bite site lasting more than 24 hours
• Hives, facial or tongue swelling, throat tightness, or breathing difficulty